RHEUMATOID ARTHRITIS: high cost drugs pathway - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

RHEUMATOID ARTHRITIS: high cost drugs pathway

Last Updated: 20 December 2018

Body System: Musculoskeletal system

Red

Failure of intensive therapy with a combination of standard DMARDs (usually methotrexate, hydroxychloroquine and sulphasalazine) and DAS28 > 5.1